Namperumalsamy Venkatesh Prajna: Influence Statistics

Namperumalsamy Venkatesh Prajna

Namperumalsamy Venkatesh Prajna

Aravind Eye Hospital, Madurai, Tamil Nadu, India | Aravind Eye Hospital, Madurai, India | Aravind Eye Hospital, Madurai, Tamil Nadu, India. | Aravind Eye Hospital, Madurai, ...

Namperumalsamy Venkatesh Prajna: Expert Impact

Concepts for which Namperumalsamy Venkatesh Prajna has direct influence: Fungal keratitis , South india , Oral voriconazole , Bacterial eye infections , Bacterial keratitis , Corneal perforation , Visual acuity .

Namperumalsamy Venkatesh Prajna: KOL impact

Concepts related to the work of other authors for which for which Namperumalsamy Venkatesh Prajna has influence: Fungal keratitis , Cataract surgery , Visual acuity , Ocular surface , Aspergillus fumigatus , Stem cell , Corneal ulcers .

KOL Resume for Namperumalsamy Venkatesh Prajna

Year
2022

Aravind Eye Hospital, Madurai, Tamil Nadu, India

2021

Aravind Eye Hospital, Madurai, India

2020

Department of Cornea and Refractive Surgery, Aravind Eye Hospital, Madurai, India. Electronic address:

Academic Director: Aravind Eye Hospital, Madurai, India.

2019

Aravind Eye Hospital, 1 Anna Nagar, Madurai, 625 020 Tamil Nadu India

2018

Cornea Department, Aravind Eye Hospital, Madurai, Tamil Nadu, India; Microbiology Department, Aravind Medical Research Foundation, Madurai, Tamil Nadu, India, View further author information

Aravind Eye Care System, Madurai, Pondicherry, and Coimbatore, India

2017

Aravind Medical Research Foundation, Madurai, Tamil Nadu, India.

2016

Department of Cornea and Refractive Surgery, Aravind Eye Hospitals and Postgraduate Institute of Ophthalmology, Madurai

2015

Aravind Eye Care System, Coimbatore, India

2014

Dr G. Venkatasamy Eye Research Institute, Aravind Eye Hospital, Tamil Nadu, India

2013

Aravind Eye Care System, Madurai (Drs N. V. Prajna, Mascarenhas, L. Prajna, and Srinivasan), Aravind Eye Care System, Pondicherry (Dr Krishnan), and Aravind Eye Care System, Coimbatore (Drs Rajaraman and Raghavan), India

2012

Aravind Eye Institute, Madurai, India

2011

Dr G. Venkatasamy Eye Research Institute, Aravind Eye Hospital, Madurai, Tamil Nadu, and

2010

Aravind Eye Hospitals, Madurai, India

2008

Department of Cornea, Aravind Eye Hospital, Madurai, India

Cornea & External Disease Service, Aravind Eye Hospital, Madurai (Drs Srinivasan, Arunkumar, and Prajna).

2007

Department of Cornea and Refractive Surgery, Aravind Eye Hospital and Postgraduate Institute of Ophthalmology, Madurai, India.

Cornea Clinic,Aravind Eye Care System, Madurai, India

2006

Departments of Cornea and Refractive Surgery, Aravind Eye Hospital and Post-graduate Institute of Ophthalmology, Madurai, India

2005

Cornea Clinic, Aravind Eye Hospital, Madurai, India

Eye Care and Surgery Center of Fort Lauderdale, 1110 SE 4th Street, Ft Lauderdale, FL 33301, USA

2004

From the Aravind Medical Research Foundation, Aravind Eye Care System, Madurai, India.

2003

From the Aravind Eye Hospital and Postgraduate Institute of Ophthalmology, Madurai 625 020, Tamilnadu, India.

Lions Aravind Institute of Community Ophthalmology, Madurai, India

2002

Aravind Eye Hospitals, Postgraduate Institute of Ophthalmology, 1 Anna Nagar, Madurai-625 020, India.

2001

From Aravind Eye Hospitals & Postgraduate Institute of Ophthalmology, Tamil Nadu, India.

2000

Aravind Eye Hospitals and Postgraduate Institute of Ophthalmology, Madurai, India

1999

Aravind Eye Hospital and Post-Graduate Institute of Ophthalmology, Madurai, India.

1998

From the Aravind Eye Hospital and Post-Graduate Institute of Ophthalmology, Madurai, India

1996

Aravind Eye Hospital, Madurai.

Prominent publications by Namperumalsamy Venkatesh Prajna

KOL-Index: 14866 . Objective: To compare oral voriconazole with placebo in addition to topical antifungals in the treatment of filamentous fungal keratitis. Design, Setting, and Participants: The Mycotic Ulcer Treatment Trial II (MUTT II), a multicenter, double-masked, placebo-controlled, randomized clinical trial, was conducted in India and Nepal, with 2133 individuals screened for inclusion. Patients with ...
Known for Oral Voriconazole | Fungal Keratitis | Ulcer Treatment | Randomized Clinical Trial
KOL-Index: 12875 . OBJECTIVE: To characterize the susceptibility of filamentous fungi isolated from keratitis to amphotericin B, natamycin, caspofungin acetate, itraconazole, voriconazole, and posaconazole. METHODS: Ninety isolates from fungal keratitis cases at Aravind Eye Hospital in South India were tested using macrobroth dilution for susceptibility to amphotericin B, natamycin, caspofungin, ...
Known for Itraconazole Voriconazole | Amphotericin Natamycin | Fusarium Species | Antimicrobial Susceptibility
KOL-Index: 12310 . OBJECTIVE: To compare topical natamycin vs voriconazole in the treatment of filamentous fungal keratitis. METHODS: This phase 3, double-masked, multicenter trial was designed to randomize 368 patients to voriconazole (1%) or natamycin (5%), applied topically every hour while awake until reepithelialization, then 4 times daily for at least 3 weeks. Eligibility included smear-positive ...
Known for Natamycin Voriconazole | Ulcer Treatment | Fusarium Cases | Visual Acuity
KOL-Index: 11405 . OBJECTIVE: To conduct a therapeutic exploratory clinical trial comparing clinical outcomes of treatment with topical natamycin vs topical voriconazole for fungal keratitis. METHODS: The multicenter, double-masked, clinical trial included 120 patients with fungal keratitis at Aravind Eye Hospital in India who were randomized to receive either topical natamycin or topical voriconazole and ...
Known for Fungal Keratitis | 3 Months | Natamycin Voriconazole | Visual Acuity
KOL-Index: 10674 . OBJECTIVE: To determine the incidence of acute-onset postcataract endophthalmitis, identify risk factors, and determine clinical outcomes in a tertiary eye care center in South India. DESIGN: Retrospective, interventional, observational case series. PARTICIPANTS: All patients who underwent cataract extraction from January 2002 to December 2003 at Aravind Eye Hospital, Madurai. METHODS: The ...
Known for South India | Postcataract Endophthalmitis | Cataract Extraction | Incidence Risk Factors
KOL-Index: 10603 . PURPOSE: To characterize human limbal epithelial cells based on the expression levels of nuclear protein p63 and the nucleus-to-cytoplasm (N/C) ratio. METHODS: Limbal, peripheral, and central corneal epithelia were separated from the stroma by Dispase II and subsequently were treated with trypsin to obtain single-cell suspensions. Cytospin smears of the cell suspensions were double ...
Known for Epithelial Cells | Confocal Microscopy | Limbal Epithelium | P63 Expression
KOL-Index: 10514 . PURPOSE: To determine the diagnostic accuracy of in vivo confocal microscopy (IVCM) for moderate to severe microbial keratitis (MK). DESIGN: Double-masked prospective cohort study. PARTICIPANTS: Consecutive patients presenting to Aravind Eye Hospital, Madurai, India, between February 2012 and February 2013 with MK (diameter ≥3 mm, excluding descemetocele, perforation, or herpetic ...
Known for Microbial Keratitis | Sensitivity Specificity | Laser Scanning | Confocal Microscopy
KOL-Index: 10446 . BACKGROUND/AIMS: To study the susceptibility of Fusarium and Aspergillus isolated from keratitis to amoxicillin, cefazolin, chloramphenicol, moxifloxacin, tobramycin and benzalkonium chloride (BAK). METHODS: 10 isolates of Fusarium and 10 isolates of Aspergillus from cases of fungal keratitis at Aravind Eye Hospital in South India were tested using microbroth dilution for susceptibility to ...
Known for Fungal Eye Infections | Activity Fusarium | Sensitivity Tests | Bacterial Agents
KOL-Index: 10345 . PURPOSE: Till date there is no exclusive marker for human corneal epithelial stem cells (CESCs). In this study, our strategy is to combine high expression of ABCG2, a putative SC marker with high N/C ratio to develop a specific method for identification of CESCs. METHODS: Limbal/corneal epithelial cells (LECs/CECs) were isolated from cadaver eyes by enzymatic treatment and the cytospin ...
Known for Stem Cells | Abcg2 Expression | Corneal Epithelial | Atp Binding
KOL-Index: 9833 . PURPOSE: To analyze the minimum inhibitory concentration (MIC) of isolates from fungal keratitis to natamycin and voriconazole and to assess the relationship between organism, MIC, and clinical outcome. METHODS: Data were collected as part of a randomized, controlled, double-masked clinical trial. Main outcome measures included best spectacle-corrected visual acuity, infiltrate/scar size, ...
Known for Clinical Trial | Natamycin Voriconazole | Inhibitory Concentration | Fungal Corneal
KOL-Index: 9830 . PURPOSE: To describe the minimum inhibitory concentration (MIC) of fungal isolates to natamycin and voriconazole, and to compare these MICs to previous ocular susceptibility studies. DESIGN: Experimental laboratory study using isolates from a randomized clinical trial. METHODS: The Mycotic Ulcer Treatment Trial I was a randomized, double-masked, multicenter trial comparing topical ...
Known for Natamycin Voriconazole | Vitro Susceptibility | Fungal Isolates | Aspergillus Species
KOL-Index: 9502 . BACKGROUND: Filamentous fungi of the genera Aspergillus and Fusarium are major causes of corneal ulcers in the United States and in the developing world and result in significant visual impairment and blindness. METHODS: RNA was extracted from 110 patients with corneal ulcers in southern India within 1 week of infection with either Fusarium solani or Aspergillus flavus, and gene expression ...
Known for Aspergillus Fusarium | Corneal Ulcers | Filamentous Fungi | Southern India
KOL-Index: 9445 . PURPOSE: To compare the efficacy and safety of ofloxacin 0.3% ophthalmic solution with ciprofloxacin 0.3% ophthalmic solution in patients with culture-positive bacterial keratitis. METHODS: Patients with a microbiologic diagnosis of bacterial keratitis were included in this double-masked, parallel-group study and were randomized to treatment with either ofloxacin 0.3% or ciprofloxacin 0.3% ...
Known for Bacterial Keratitis | Ophthalmic Solutions | Ofloxacin 03 | Corneal Ulcer
KOL-Index: 9261 . PURPOSE: To estimate the cumulative incidence of posterior capsule opacification 4 years after surgery in patients who participated in the Madurai Intraocular Lens Study and had extracapsular cataract extraction with posterior chamber intraocular lens implantation. METHODS: In the Madurai Intraocular Lens Study, 1,700 patients with best-corrected visual acuity 20/120 or worse in the better ...
Known for Posterior Capsule Opacification | Intraocular Lens | Laser Capsulotomy | Cataract Extraction
KOL-Index: 9091 . PURPOSE: To determine risk factors and clinical signs that may differentiate between bacterial, fungal, and acanthamoeba keratitis among patients presenting with presumed infectious keratitis. DESIGN: Hospital-based cross-sectional study. METHODS: We examined the medical records of 115 patients with laboratory-proven bacterial keratitis, 115 patients with laboratory-proven fungal ...
Known for Bacterial Keratitis | Patients Acanthamoeba | Medical Records | Differential Eye Infections

Key People For Fungal Keratitis

Top KOLs in the world
#1
Philip Aloysius Thomas
wistar rats cataract surgery mycotic keratitis
#2
Prashant Garg
fungal keratitis ocular infections corneal scrapings
#3
Savitri Sharma
fungal keratitis corneal scrapings cataract surgery
#4
Eduardo C Alfonso
fungal keratitis contact lens visual acuity
#5
Muthiah Srinivasan
south india bacterial keratitis corneal ulcers
#6
Namperumalsamy Venkatesh Prajna
fungal keratitis south india oral voriconazole

Aravind Eye Hospital, Madurai, Tamil Nadu, India | Aravind Eye Hospital, Madurai, India | Aravind Eye Hospital, Madurai, Tamil Nadu, India. | Aravind Eye Hospital, Madurai, India. | Department of Cornea and Refractive Services, Aravind Eye Hospital,